A Phase 1, Open-Label, Multiple-Dose Study of KHK4083 in Subjects with Atopic Dermatitis
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 21 Sep 2017
At a glance
- Drugs KHK 4083 (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- Sponsors Kyowa Hakko Kirin
- 15 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 14 Sep 2017 Planned End Date changed from 1 Jun 2018 to 1 Feb 2018.
- 14 Sep 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Feb 2018.